SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-13-011744
Filing Date
2013-09-09
Accepted
2013-09-09 10:38:07
Documents
27
Period of Report
2013-09-09
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K clsn20130909_8k.htm 8-K 31053
2 EXHIBIT 99.1 ex99-1.htm EX-99 16021
3 slide25.jpg GRAPHIC 39762
4 slide24.jpg GRAPHIC 39477
5 slide23.jpg GRAPHIC 68317
6 slide22.jpg GRAPHIC 72429
7 slide21.jpg GRAPHIC 71883
8 slide20.jpg GRAPHIC 57598
9 slide19.jpg GRAPHIC 83412
10 slide18.jpg GRAPHIC 65968
11 slide17.jpg GRAPHIC 91795
12 slide16.jpg GRAPHIC 94949
13 slide15.jpg GRAPHIC 67161
14 slide14.jpg GRAPHIC 60417
15 slide13.jpg GRAPHIC 62921
16 slide12.jpg GRAPHIC 77079
17 slide11.jpg GRAPHIC 88370
18 slide10.jpg GRAPHIC 76722
19 slide9.jpg GRAPHIC 84188
20 slide8.jpg GRAPHIC 80170
21 slide7.jpg GRAPHIC 56344
22 slide6.jpg GRAPHIC 66401
23 slide5.jpg GRAPHIC 76638
24 slide4.jpg GRAPHIC 96070
25 slide3.jpg GRAPHIC 79596
26 slide2.jpg GRAPHIC 57124
27 slide1.jpg GRAPHIC 43454
  Complete submission text file 0001437749-13-011744.txt   2473741
Mailing Address 997 LENOX DRIVE SUITE 100 LAWRENCEVILLE NJ 08648
Business Address 997 LENOX DRIVE SUITE 100 LAWRENCEVILLE NJ 08648 (609) 896-9100
Celsion CORP (Filer) CIK: 0000749647 (see all company filings)

IRS No.: 521256615 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-15911 | Film No.: 131084580
SIC: 2834 Pharmaceutical Preparations